Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67076-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- TFAP2A,AP-2 antibody
- Antibody type
- Monoclonal
- Description
- TFAP2A,AP-2 antibody (Cat. #67076-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B12F11
- Vial size
- 20ul, 150ul
Submitted references HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability.
TFAP2A upregulates FAM83A to suppress ferroptosis and diminish cisplatin sensitivity in non-small cell lung cancer.
Identifification and validation of ferroptosis signatures and immune infifiltration characteristics associated with intervertebral disc degeneration.
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
Liao M, Li C, Yang R, Li J, Wu K, Zhang J, Zhu Q, Shi Y, Zhang X
Cancer cell international 2025 Mar 8;25(1):85
Cancer cell international 2025 Mar 8;25(1):85
TFAP2A upregulates FAM83A to suppress ferroptosis and diminish cisplatin sensitivity in non-small cell lung cancer.
Sun Q, Qu W, Wang Y, Yang K, Weng Y
Cell division 2025 Jul 11;20(1):19
Cell division 2025 Jul 11;20(1):19
Identifification and validation of ferroptosis signatures and immune infifiltration characteristics associated with intervertebral disc degeneration.
Zhang F, Cui D, Wang K, Cheng H, Zhai Y, Jiao W, Wang Z, Cui X, Yu H
Frontiers in genetics 2023;14:1133615
Frontiers in genetics 2023;14:1133615
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
Yang J, Gao Y, Yao S, Wan S, Cai H
Oncology reports 2023 Jun;49(6)
Oncology reports 2023 Jun;49(6)
No comments: Submit comment
No validations: Submit validation data